In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Abramson Cancer Center at Penn Medicine
DEKA Biosciences
Thomas Jefferson University
Thomas Jefferson University
Ohio State University Comprehensive Cancer Center
Stanford University
M.D. Anderson Cancer Center
Dong-A University
University of Utah
Dong-A University
Dong-A University
Northwestern University
Fred Hutchinson Cancer Center